Agilent TechnologiesFRA:AG8 -0.74%94 Gross Margin % is 53.95% as of Apr. 2026, which is 0% above its 10-year median of 53.78. GuruFocus rates FRA:AG8 with a GF Score™ of 94/100 and a GF Value™ of €127.52 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 194 Medical Diagnostics & Research companies, Agilent Technologies ranks better than 52.58% on this metric.
The historical rank and industry rank for Agilent Technologies's Gross Margin % or its related term are showing as below:
FRA:AG8'
s Gross Margin % Range Over the Past 10 Years
Min: 50.71 Med: 53.78 Max: 54.54
Current: 52.74
During the past 13 years, the highestGross Margin % of Agilent Technologies was 54.54%. The lowest was 50.71%. And the median was 53.78%.
FRA:AG8's Gross Margin % is ranked better than 52.58% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 51.14
vs FRA:AG8: 52.74
Agilent Technologies had a gross margin of 53.95% for the quarter that ended in Apr. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Agilent Technologies was -0.30% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Agilent Technologies had a gross margin of 53.95% for the quarter that ended in Apr. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Agilent Technologies Gross Margin % Related Terms
Agilent Technologies Gross Margin % Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:AG8 vs NTRA, WAT, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Agilent Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Agilent Technologies (FRA:AG8) has a Gross Margin % of 53.95% as of Apr. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Agilent Technologies and its competitors. This is near median its historical median of 53.78. Over the past decade, Agilent Technologies' Gross Margin % has ranged from 50.71 to 54.54. According to the industry distribution chart, Agilent Technologies ranks #92 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 47.4%.
Is Agilent Technologies' Gross Margin % too high?
Agilent Technologies' current Gross Margin % of 53.95% is near median its 10-year median of 53.78. Over the past 10 years, this metric has ranged from a low of 50.71 to a high of 54.54. The Medical Diagnostics & Research industry median Gross Margin % is 51.14. Agilent Technologies' value of 53.95% is 5.5% above this industry median. Based on the distribution chart, Agilent Technologies ranks #92 out of 194 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Agilent Technologies has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' Gross Margin % compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #92 out of 194 companies for Gross Margin %. This puts Agilent Technologies in the upper half of its industry. The industry median Gross Margin % is 51.14. Agilent Technologies' value of 53.95% is 5.5% above this benchmark. Historically, Agilent Technologies' own Gross Margin % has ranged from 50.71 to 54.54 over the past decade. While the company's 10-year median is 53.78 vs. the industry median of 51.14, Agilent Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 51.14, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilent Technologies's current Gross Margin % of 53.95% is 5.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Agilent Technologies and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 51.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilent Technologies's current Gross Margin % is 53.95%, which is near median its own 10-year median of 53.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (FRA:AG8) is currently considered Modestly Undervalued. The stock's GF Value™ is €127.52, compared to a current price of €113.65 — trading 10.9% below its estimated fair value. The current Gross Margin % is 53.95%, which is near median its 10-year median of 53.78 and 5.5% above the Medical Diagnostics & Research industry median of 51.14. Agilent Technologies' overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Agilent Technologies (FRA:AG8), the current Gross Margin % is 53.95% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (FRA:AG8) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of €113.65 is trading 10.9% below its estimated GF Value™ of €127.52.
GuruFocus considers Agilent Technologies to be Modestly Undervalued.
Key valuation signals for FRA:AG8:
Gross Margin %: 53.95% (near median its 10-year median of 53.78)
GF Value™: €127.52 vs. price of €113.65 (10.9% below fair value)
Industry Position: 5.5% above the Medical Diagnostics & Research median (#92 of 194)
No single metric tells the full story. See the FRA:AG8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
94GF Score
Get the complete analysis for FRA:AG8
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AG8 has been successfully added to your 
